Latest Minocycline Stories
One of the antibiotics most commonly prescribed to treat adolescent acne can increase attention spans and communication and decrease anxiety in patients with fragile X syndrome, the most common inherited cause of mental impairment.
A daily dose of an old antibiotic may help diabetics avoid a stroke or at least minimize its damage, Medical College of Georgia researchers report.
New research suggests that acne antibiotics prescribed to help control breakouts may lead to inflammatory bowel disease.
PITTSBURGH, July 22 /PRNewswire-FirstCall/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Matrix Laboratories Limited received final approval on July 20 from the U.S.
CLEVELAND, March 23 /PRNewswire/ -- Magellan Biosciences, Inc., an emerging leader in clinical diagnostics products, announced that the company has become the first to offer minocycline and telavancin on IVD-labeled microbroth dilution susceptibility plates. The U.S.
Johns Hopkins scientists have found that a safe and inexpensive antibiotic in use since the 1970s for treating acne effectively targets infected immune cells in which HIV, the virus that causes AIDS, lies dormant and prevents them from reactivating and replicating.
WALNUT CREEK, Calif., Dec. 8 /PRNewswire/ -- The National Fragile X Foundation has awarded a translational research seed grant of $100,000 to Dr. Randi J. Hagerman at the UC Davis M.I.N.D. Institute in California for a study of minocycline in the treatment of children with fragile X syndrome (FXS).
The antibiotic minocycline may revolutionize the treatment of strokes. A new study, published in the open access journal BMC Neuroscience, describes the safety and therapeutic efficacy of the drug in animal models.
SCOTTSDALE, Ariz., Nov. 11, 2008 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced that the Company is scheduled to present at the 2008 Credit Suisse Healthcare Conference in Phoenix, Arizona. A live webcast of its presentation scheduled for Thursday, November 13, 2008, at 11:30 a.m.
SCOTTSDALE, Ariz., Nov. 6, 2008 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced it expects to report 2008 third quarter financial results after the market closes on Monday, November 10, 2008. Medicis will host a conference call at 5:15 p.m. Eastern Time (2:15 p.m.